查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386283

癌症疫苗市場報告：2030 年趨勢、預測與競爭分析

Cancer Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

癌症疫苗趨勢和預測

預計到 2030 年，全球癌症疫苗市場將達到 155 億美元，2024 年至 2030 年複合年成長率為 10.5%。該市場的主要促進因素包括對更有效、侵入性更小的癌症治療的需求不斷成長、人們對癌症疫苗益處的認知不斷提高以及政府促進癌症疫苗接種的支持措施。全球癌症疫苗市場前景廣闊，醫院和政府供應管道充滿機會。

癌症疫苗市場洞察

Lucintel 預測，預防癌症發作的預防性疫苗預計將在預測期內達到最高成長。

在這個市場中，由於在醫院接受癌症診斷和治療的人數不斷增加，醫院在預測期內預計將出現高速成長。

由於癌症患者數量的增加和醫療保健系統的建立，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而促使市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球癌症疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球癌症疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依疫苗類型分類的全球癌症疫苗市場
    • 預防
    • 治療性的
  • 依技術分類的全球癌症疫苗市場
    • 重組
    • 全細胞
    • 病毒載體
    • DNA癌症疫苗
  • 依配銷通路分類的全球癌症疫苗市場
    • 醫院
    • 政府供應商

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球癌症疫苗市場依地區分類
  • 北美癌症疫苗市場
  • 歐洲癌症疫苗市場
  • 亞太地區癌症疫苗市場
  • 其他區域癌症疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依疫苗類型分類的全球癌症疫苗市場成長機會
    • 全球癌症疫苗市場成長機會（依技術）
    • 全球癌症疫苗市場成長機會（依配銷通路）
    • 全球癌症疫苗市場成長機會（依地區）
  • 全球癌症疫苗市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球癌症疫苗市場的產能
    • 全球癌症疫苗市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • AstraZeneca
  • Bristol-Myers Squibb
簡介目錄

Cancer Vaccine Trends and Forecast

The future of the global cancer vaccine market looks promising with opportunities in the hospital and government supplier channels. The global cancer vaccine market is expected to reach an estimated $15.5 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising demand for more effective and less invasive cancer treatment, growing awareness of the benefits of cancer vaccines, and supportive government initiatives to promote cancer vaccination.

A more than 150-page report is developed to help in your business decisions.

Cancer Vaccine by Segment

The study includes a forecast for the global cancer vaccine by vaccine type, technology, distribution channel, and region.

Cancer Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Preventive
  • Therapeutic

Cancer Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Recombinant
  • Whole-Cell
  • Viral Vector
  • DNA Cancer Vaccines

Cancer Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Government Suppliers

Cancer Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cancer Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer vaccine companies profiled in this report include-

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • Astrazeneca
  • Bristol-Myers Squibb

Cancer Vaccine Market Insights

Lucintel forecasts that preventive is expected to witness highest growth over the forecast period due to its ability to prevent cancer from developing in the first place.

Within this market, hospital is expected to witness higher growth over the forecast period due to the increasing number of individuals seeking cancer diagnosis and treatment in hospitals.

North America is expected to witness highest growth over the forecast period due to the rising number of cancer patients and presence of well-established healthcare system in the region.

Features of the Global Cancer Vaccine Market

Market Size Estimates: Cancer vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cancer vaccine market size by vaccine type, technology, distribution channel, and region in terms of value ($B).

Regional Analysis: Cancer vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, distribution channels, and regions for the cancer vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cancer vaccine market size?

Answer: The global cancer vaccine market is expected to reach an estimated $15.5 billion by 2030.

Q.2 What is the growth forecast for cancer vaccine market?

Answer: The global cancer vaccine market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cancer vaccine market?

Answer: The major drivers for this market are rising demand for more effective and less invasive cancer treatment, growing awareness of the benefits of cancer vaccines, and supportive government initiatives to promote cancer vaccination.

Q4. What are the major segments for cancer vaccine market?

Answer: The future of the cancer vaccine market looks promising with opportunities in the hospital and government supplier channels.

Q5. Who are the key cancer vaccine market companies?

Answer: Some of the key cancer vaccine companies are as follows:

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • Astrazeneca
  • Bristol-Myers Squibb

Q6. Which cancer vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that preventive is expected to witness highest growth over the forecast period due to its ability to prevent cancer from developing in the first place.

Q7. In cancer vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the rising number of cancer patients and presence of well-established healthcare system in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cancer vaccine market by vaccine type (preventive and therapeutic), technology (recombinant, whole-cell, viral vector, and dna cancer vaccines), distribution channel (hospitals and government suppliers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cancer Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cancer Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cancer Vaccine Market by Vaccine Type
    • 3.3.1: Preventive
    • 3.3.2: Therapeutic
  • 3.4: Global Cancer Vaccine Market by Technology
    • 3.4.1: Recombinant
    • 3.4.2: Whole-Cell
    • 3.4.3: Viral Vector
    • 3.4.4: DNA Cancer Vaccines
  • 3.5: Global Cancer Vaccine Market by Distribution Channel
    • 3.5.1: Hospitals
    • 3.5.2: Government Suppliers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cancer Vaccine Market by Region
  • 4.2: North American Cancer Vaccine Market
    • 4.2.2: North American Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.3: European Cancer Vaccine Market
    • 4.3.1: European Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.3.2: European Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.4: APAC Cancer Vaccine Market
    • 4.4.1: APAC Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.4.2: APAC Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.5: ROW Cancer Vaccine Market
    • 4.5.1: ROW Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.5.2: ROW Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cancer Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Cancer Vaccine Market by Technology
    • 6.1.3: Growth Opportunities for the Global Cancer Vaccine Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Cancer Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cancer Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cancer Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: GSK
  • 7.3: Dendreon Pharmaceuticals
  • 7.4: Dynavax Technologies
  • 7.5: Ferring
  • 7.6: Amgen
  • 7.7: Moderna
  • 7.8: Sanofi
  • 7.9: AstraZeneca
  • 7.10: Bristol-Myers Squibb